Literature DB >> 19193851

Repurposing libraries of eukaryotic protein kinase inhibitors for antibiotic discovery.

Christopher T Walsh1, Michael A Fischbach.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19193851      PMCID： PMC2644097          DOI： 10.1073/pnas.0813405106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  9 in total

1.  A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Authors:  Koen Andries; Peter Verhasselt; Jerome Guillemont; Hinrich W H Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

2.  Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.

Authors:  Heike Brötz-Oesterhelt; Dieter Beyer; Hein-Peter Kroll; Rainer Endermann; Christoph Ladel; Werner Schroeder; Berthold Hinzen; Siegfried Raddatz; Holger Paulsen; Kerstin Henninger; Julia E Bandow; Hans-Georg Sahl; Harald Labischinski
Journal:  Nat Med       Date:  2005-10-02       Impact factor: 53.440

Review 3.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

4.  ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds.

Authors:  Gemma Triola; Stefan Wetzel; Bernhard Ellinger; Marcus A Koch; Katja Hübel; Daniel Rauh; Herbert Waldmann
Journal:  Bioorg Med Chem       Date:  2008-02-16       Impact factor: 3.641

5.  Platensimycin is a selective FabF inhibitor with potent antibiotic properties.

Authors:  Jun Wang; Stephen M Soisson; Katherine Young; Wesley Shoop; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Gopalakrishnan Parthasarathy; Yui S Tang; Richard Cummings; Sookhee Ha; Karen Dorso; Mary Motyl; Hiranthi Jayasuriya; John Ondeyka; Kithsiri Herath; Chaowei Zhang; Lorraine Hernandez; John Allocco; Angela Basilio; José R Tormo; Olga Genilloud; Francisca Vicente; Fernando Pelaez; Lawrence Colwell; Sang Ho Lee; Bruce Michael; Thomas Felcetto; Charles Gill; Lynn L Silver; Jeffery D Hermes; Ken Bartizal; John Barrett; Dennis Schmatz; Joseph W Becker; Doris Cully; Sheo B Singh
Journal:  Nature       Date:  2006-05-18       Impact factor: 49.962

6.  A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.

Authors:  Chia-I Liu; George Y Liu; Yongcheng Song; Fenglin Yin; Mary E Hensler; Wen-Yih Jeng; Victor Nizet; Andrew H-J Wang; Eric Oldfield
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

7.  Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activity.

Authors:  Christoph Freiberg; Nina A Brunner; Guido Schiffer; Thomas Lampe; Jens Pohlmann; Michael Brands; Martin Raabe; Dieter Häbich; Karl Ziegelbauer
Journal:  J Biol Chem       Date:  2004-04-02       Impact factor: 5.157

8.  Structural evidence for substrate-induced synergism and half-sites reactivity in biotin carboxylase.

Authors:  Igor Mochalkin; J Richard Miller; Artem Evdokimov; Sandra Lightle; Chunhong Yan; Charles Ken Stover; Grover L Waldrop
Journal:  Protein Sci       Date:  2008-08-25       Impact factor: 6.725

9.  A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore.

Authors:  J Richard Miller; Steve Dunham; Igor Mochalkin; Craig Banotai; Matthew Bowman; Susan Buist; Bill Dunkle; Debra Hanna; H James Harwood; Michael D Huband; Alla Karnovsky; Michael Kuhn; Chris Limberakis; Jia Y Liu; Shawn Mehrens; W Thomas Mueller; Lakshmi Narasimhan; Adam Ogden; Jeff Ohren; J V N Vara Prasad; John A Shelly; Laura Skerlos; Mark Sulavik; V Hayden Thomas; Steve VanderRoest; LiAnn Wang; Zhigang Wang; Amy Whitton; Tong Zhu; C Kendall Stover
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-22       Impact factor: 11.205
  9 in total
  13 in total

1.  HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis.

Authors:  Yonghui Zhang; Kai Li; Wei Zhu; Yi-Liang Liu; Rong Cao; Ran Pang; Eunhae Lee; Jordan Axelson; Mary Hensler; Ke Wang; Katie J Molohon; Yang Wang; Douglas A Mitchell; Victor Nizet; Eric Oldfield
Journal:  ACS Med Chem Lett       Date:  2012-04-03       Impact factor: 4.345

Review 2.  The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.

Authors:  L Hedstrom; G Liechti; J B Goldberg; D R Gollapalli
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.

Authors:  Deviprasad R Gollapalli; Iain S Macpherson; George Liechti; Suresh Kumar Gorla; Joanna B Goldberg; Lizbeth Hedstrom
Journal:  Chem Biol       Date:  2010-10-29

Review 4.  The Future of Antifungal Drug Therapy: Novel Compounds and Targets.

Authors:  Caroline Mota Fernandes; Deveney Dasilva; Krupanandan Haranahalli; J Brian McCarthy; John Mallamo; Iwao Ojima; Maurizio Del Poeta
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

5.  N-O chemistry for antibiotics: discovery of N-alkyl-N-(pyridin-2-yl)hydroxylamine scaffolds as selective antibacterial agents using nitroso Diels-Alder and ene chemistry.

Authors:  Timothy A Wencewicz; Baiyuan Yang; James R Rudloff; Allen G Oliver; Marvin J Miller
Journal:  J Med Chem       Date:  2011-09-15       Impact factor: 7.446

6.  Identification, in vitro activity and mode of action of phosphoinositide-dependent-1 kinase inhibitors as antifungal molecules.

Authors:  Bonnie K Baxter; Louis DiDone; Duana Ogu; Stanford Schor; Damian J Krysan
Journal:  ACS Chem Biol       Date:  2011-02-22       Impact factor: 5.100

7.  Predicting new indications for approved drugs using a proteochemometric method.

Authors:  Sivanesan Dakshanamurthy; Naiem T Issa; Shahin Assefnia; Ashwini Seshasayee; Oakland J Peters; Subha Madhavan; Aykut Uren; Milton L Brown; Stephen W Byers
Journal:  J Med Chem       Date:  2012-07-25       Impact factor: 7.446

8.  FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules.

Authors:  Hongyi Zhou; Hongnan Cao; Jeffrey Skolnick
Journal:  J Chem Inf Model       Date:  2018-10-16       Impact factor: 4.956

9.  Predicting new molecular targets for known drugs.

Authors:  Michael J Keiser; Vincent Setola; John J Irwin; Christian Laggner; Atheir I Abbas; Sandra J Hufeisen; Niels H Jensen; Michael B Kuijer; Roberto C Matos; Thuy B Tran; Ryan Whaley; Richard A Glennon; Jérôme Hert; Kelan L H Thomas; Douglas D Edwards; Brian K Shoichet; Bryan L Roth
Journal:  Nature       Date:  2009-11-01       Impact factor: 49.962

10.  Enhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian models.

Authors:  Sean Ekins; Robert C Reynolds; Scott G Franzblau; Baojie Wan; Joel S Freundlich; Barry A Bunin
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.